X4 Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.

About XFOR

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. 

CEO
Paula S. Ragan, PhD
CEOPaula S. Ragan, PhD
Employees
143
Employees143
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2010
Founded2010
Employees
143
Employees143

XFOR Key Statistics

Market cap
71.05M
Market cap71.05M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
Dividend yield
Average volume
371.19K
Average volume371.19K
High today
$3.42
High today$3.42
Low today
$2.83
Low today$2.83
Open price
$3.30
Open price$3.30
Volume
531.84K
Volume531.84K
52 Week high
$26.83
52 Week high$26.83
52 Week low
$1.35
52 Week low$1.35

People also own

Based on the portfolios of people who own XFOR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.